ArticlePloS one2011

Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC.

Edwin de Jong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.